Navigation Links
Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
Date:2/27/2008

LITTLE ROCK, Ark., Feb. 27 /PRNewswire/ -- Cauley Bowman Carney & Williams, PLLC announces an investigation into the proposed acquisition of CollaGenex Pharmaceuticals, Inc. (Nasdaq: CGPI). On February 26, 2008, CollaGenex announced that it has entered into a definitive merger agreement with an affiliate of Galderma Pharma S.A. Under the terms of the proposal, CollaGenex's shareholders would receive $16.60 per share in cash for each share owned. This price per share represents an approximately 33% premium over the stock's closing price of $16.23 prior to announcement of the acquisition.

Cauley Bowman Carney & Williams, PLLC

Cauley Bowman is a national law firm that represents investors in securities fraud and corporate governance class actions. It is one of the country's premier firms in the area of securities fraud having recovered billions of dollars for defrauded investors and secured significant corporate governance reforms. Cauley Bowman maintains in-house finance, forensic accounting specialists and extensive trial experience.

If you are a current shareholder of CollaGenex Pharmaceuticals, Inc. and would like to be advised of your rights in this matter, you may contact Cauley Bowman Carney & Williams, PLLC at the phone number below.

CONTACT

Darrin L. Williams, Esq.

Randall K. Pulliam, Esq.

Kristi Gray

501-312-8500

1-888-551-9944

info@cauleybowman.com


'/>"/>
SOURCE Cauley Bowman Carney & Williams, PLLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
2. DuPont Leaders Brief Investors on Agriculture Businesses
3. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
4. Thermo Fisher Scientific to Present at Investor Conferences
5. Modigene to Present at the Roth 2007 New York Investor Conference
6. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
9. Suntech to Attend Upcoming Investor Conferences and Industry Events
10. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
11. American Oriental Bioengineering Announces Participation in September Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , ... announced today the Clinical Reach Virtual Patient Encounter CONSULT module which enables ... the physician and clinical trial team. , Using the CONSULT module, patients and physicians ...
(Date:6/27/2016)...   Ginkgo Bioworks , a leading organism ... today awarded as one of the World Economic ... most innovative companies. Ginkgo Bioworks is engineering biology ... world in the nutrition, health and consumer goods ... customers including Fortune 500 companies to design microbes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/26/2016)... and LONDON , ... Finacle, part of EdgeVerve Systems, a product subsidiary ... Onegini today announced a partnership to integrate the ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... provide their customers enhanced security to access and ...
Breaking Biology News(10 mins):